hepacivirus / genetics

Explore academic connections and research related to this keyword

244
Views
8
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
Alter MJ;Kruszon-Moran D;Nainan OV;McQuillan GM;Gao F;Moyer LA;Kaslow RA;Margolis HS;;
1999 The New England journal of medicine 359 views
2
Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct-acting antivirals
Schütz A;Moser S;Schwanke C;Schubert R;Luhn J;Gutic E;Lang T;Schleicher M;Haltmayer H;Gschwantler M;...
2018 journal of viral hepatitis 330 views
3
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis
Asselah T;Kowdley KV;Zadeikis N;Wang S;Hassanein T;Horsmans Y;Colombo M;Calinas F;Aguilar H;de Ledin...
2018 clinical gastroenterology and hepatology : the off... 328 views
4
Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study
Boglione L;Mornese Pinna S;De Nicolò A;Cusato J;Cariti G;Di Perri G;D'Avolio A;;
2017 journal of viral hepatitis 351 views
5
Acute hepatitis B in patients with or without underlying chronic HCV infection
Biliotti E;Kondili LA;Furlan C;Ferretti G;Zacharia S;De Angelis M;Guidi S;Gusman N;Taliani G;;
2008 the journal of infection 308 views
6
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis
Asselah T;Bourgeois S;Pianko S;Zeuzem S;Sulkowski M;Foster GR;Han L;McNally J;Osinusi A;Brainard DM;...
2018 liver international : official journal of the inte... 280 views
7
Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C
Younossi ZM;Stepanova M;Henry L;Gane E;Jacobson IM;Lawitz E;Nelson D;Gerber L;Nader F;Hunt S;;
2014 clinical gastroenterology and hepatology : the off... 279 views
8
Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial
Lawitz E;Gane E;Pearlman B;Tam E;Ghesquiere W;Guyader D;Alric L;Bronowicki JP;Lester L;Sievert W;Gha...
2015 Lancet (London, England) 277 views

Related Journals

No Journals Found

No journals are currently associated with this keyword.

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

hepatitis c National Center for Biotechnology Information NCBI NLM MEDLINE RNA humans pubmed abstract nih national institutes of health national library of medicine adult female male adolescent aged middle aged united states / epidemiology Child risk factors